With gene editing tools becoming advanced enough to realise therapeutic potential, decision-makers working in academia and pharma are looking to consolidate their techniques to facilitate disease modelling, drug development and clinical studies.
The NextGen Genomics Series US includes...
Over 350 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.
Over 80 case studies, solution & technology presentations and 2 interactive workshops over the 2 days.
Genome Editing - Agenda at a Glance
07 April 2019 – Day One
08 April 2019 – Day Two